MyJournals Home  

RSS FeedsFinal outcomes of escalated melphalan 280 mg/m2 with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival (Bone Marrow Transplantation)

 
 

19 june 2018 05:01:34

 
Final outcomes of escalated melphalan 280 mg/m2 with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival (Bone Marrow Transplantation)
 




 
146 viewsCategory: Medicine, Pathology
 
Extracorporeal photopheresis is a valuable treatment option in steroid-refractory or steroid-dependent acute graft versus host disease--experience with three different approaches (Bone Marrow Transplantation)
Strategies to enhance the graft versus tumour effect after allogeneic haematopoietic stem cell transplantation (Bone Marrow Transplantation)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pathology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten